Indonesia has entered the monitoring stage of phase three clinical trials for the Chinese-developed vaccine Sinovac.
The monitoring phase is being conducted to determine the vaccine’s efficacy, immunogenicity and ensure its safety.
WATCH MORE: https://thestartv.com/c/news
SUBSCRIBE: https://cutt.ly/TheStar
LIKE: https://fb.com/TheStarOnline
